• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Russia approves second COVID-19 vaccine expresspharma
    October 16, 2020
    The vaccine, developed by the Vector Institute in Siberia, completed early-stage human trials last month but the results have not been published yet and Phase III, trials have not yet begun.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service